300194 Stock Overview
Research and develops, produces, and sells chemical drugs in the People's Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Fuan Pharmaceutical (Group) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.79 |
| 52 Week High | CN¥5.15 |
| 52 Week Low | CN¥2.92 |
| Beta | 0.16 |
| 11 Month Change | -4.53% |
| 3 Month Change | -6.42% |
| 1 Year Change | -2.82% |
| 33 Year Change | -13.27% |
| 5 Year Change | n/a |
| Change since IPO | -22.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300194 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.3% | -3.3% | -1.5% |
| 1Y | -2.8% | -17.6% | -18.3% |
Return vs Industry: 300194 exceeded the CN Pharmaceuticals industry which returned -17.1% over the past year.
Return vs Market: 300194 exceeded the CN Market which returned -18.5% over the past year.
Price Volatility
| 300194 volatility | |
|---|---|
| 300194 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300194 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300194's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 3,292 | n/a | www.fapharm.com |
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd.
Fuan Pharmaceutical (Group) Co., Ltd. Fundamentals Summary
| 300194 fundamental statistics | |
|---|---|
| Market cap | CN¥4.51b |
| Earnings (TTM) | CN¥268.35m |
| Revenue (TTM) | CN¥2.77b |
16.3x
P/E Ratio1.6x
P/S RatioIs 300194 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300194 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.77b |
| Cost of Revenue | CN¥1.39b |
| Gross Profit | CN¥1.38b |
| Other Expenses | CN¥1.11b |
| Earnings | CN¥268.35m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 49.81% |
| Net Profit Margin | 9.70% |
| Debt/Equity Ratio | 17.8% |
How did 300194 perform over the long term?
See historical performance and comparison